These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 23958483

  • 21. Efficacy of the long-acting octreotide formulation in patients with thyroid-stimulating hormone-secreting pituitary adenomas after incomplete surgery and octreotide treatment failure.
    Zhang CF, Liang D, Zhong LY.
    Chin Med J (Engl); 2012 Aug; 125(15):2758-63. PubMed ID: 22931988
    [Abstract] [Full Text] [Related]

  • 22. [Effect of long-term treatment with octreotide-lar in a TSH-secreting pituitary macroadenoma and secondary hyperthyroidism].
    Del Monte P, Bernasconi D, Ruelle A, Marugo A, Marugo M, Torre R.
    Minerva Endocrinol; 2005 Jun; 30(2):95-9. PubMed ID: 15988405
    [Abstract] [Full Text] [Related]

  • 23. Effects of preoperative octreotide treatment on different subtypes of 90 GH-secreting pituitary adenomas and outcome in one surgical centre.
    Abe T, Lüdecke DK.
    Eur J Endocrinol; 2001 Aug; 145(2):137-45. PubMed ID: 11454508
    [Abstract] [Full Text] [Related]

  • 24. Reversible shrinkage of a growth hormone-secreting pituitary adenoma by a long-acting somatostatin analogue, octreotide.
    Barakat S, Melmed S.
    Arch Intern Med; 1989 Jun; 149(6):1443-5. PubMed ID: 2730266
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Thyrotropin secreting pituitary adenoma accompanying a silent somatotropinoma.
    Berker D, Isik S, Aydin Y, Tutuncu Y, Akdemir G, Ozcan HN, Guler S.
    Turk Neurosurg; 2011 Jun; 21(3):403-7. PubMed ID: 21845579
    [Abstract] [Full Text] [Related]

  • 28. The treatment of a thyrotropin-secreting pituitary macroadenoma with octreotide in twin pregnancy.
    Blackhurst G, Strachan MW, Collie D, Gregor A, Statham PF, Seckl JE.
    Clin Endocrinol (Oxf); 2002 Sep; 57(3):401-4. PubMed ID: 12201834
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Thyreotropic adenoma: review of the literature. Apropos of 2 cases].
    Prévost G, Vantyghem MC, Hober C, Evrard A, Huglo D, Bonneville L, Epelbaum J, Lefebvre J.
    Ann Endocrinol (Paris); 1996 Sep; 57(3):194-202. PubMed ID: 8949414
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Reduction in size of a thyrotropin-secreting pituitary adenoma treated with octreotide acetate (somatostatin analog).
    Lee EJ, Kim KR, Lim SK, Lee HC, Kim DI, Kim SH, Huh KB.
    Eur J Endocrinol; 1994 Jul; 131(1):109-12. PubMed ID: 8038902
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.